Scholar Rock Holding Co. (NASDAQ: SRRK) director Jeffrey S. Flier sold 500 shares in a trade that took place on Monday, September 20. The stock was sold for an average price of $ 34.09, for a total value of $ 17,045.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

SRRK shares traded up $ 0.15 at midday on Tuesday, reaching $ 34.24. The company had a trading volume of 120,142 shares, compared to an average volume of 269,400. Scholar Rock Holding Co. has a twelve-month low of $ 13.30 and a twelve-month high of $ 70.00. The company has a debt to equity ratio of 0.11, a current ratio of 4.33 and a rapid ratio of 4.33. The company’s 50-day moving average is $ 36.27 and its 200-day moving average is $ 36.21. The company has a market cap of $ 1.18 billion, a P / E ratio of -10.72 and a beta of 0.13.

Scholar Rock (NASDAQ: SRRK) last released its quarterly results on Monday, August 9. The company reported ($ 0.84) earnings per share for the quarter, missing Zacks’ ($ 0.06) consensus estimate ($ 0.78). Scholar Rock had a negative net margin of 687.82% and a negative return on equity of 55.58%. The company posted revenue of $ 4.60 million for the quarter, compared to analysts’ estimate of $ 5.25 million. During the same period of the previous year, the company made earnings per share ($ 0.65). The company’s revenue for the quarter increased 17.9% year-over-year. As a group, equity analysts expect Scholar Rock Holding Co. to post -3.18 EPS for the current fiscal year.

A number of hedge funds have recently increased or reduced their holdings in SRRK. Lord Abbett & CO. LLC increased its stake in Scholar Rock by 292.5% during the 1st quarter. Lord Abbett & CO. LLC now owns 781,111 shares of the company valued at $ 39,571,000 after purchasing an additional 582,126 shares during the last quarter. State Street Corp increased its stake in Scholar Rock by 41.5% during the 2nd quarter. State Street Corp now owns 1,739,440 shares of the company valued at $ 50,270,000 after purchasing an additional 510,413 shares last quarter. Price T Rowe Associates Inc. MD increased its stake in Scholar Rock by 9.9% during the second quarter. Price T Rowe Associates Inc. MD now owns 4,820,037 shares of the company valued at $ 139,299,000 after purchasing an additional 433,188 shares during the last quarter. Morgan Stanley increased its stake in Scholar Rock by 312.4% during the 2nd quarter. Morgan Stanley now owns 352,251 shares of the company valued at $ 10,180,000 after purchasing an additional 266,841 shares in the last quarter. Finally, Goldman Sachs Group Inc. increased its stake in Scholar Rock by 276.7% during the first quarter. Goldman Sachs Group Inc. now owns 255,222 shares of the company valued at $ 12,929,000 after purchasing an additional 187,477 shares in the last quarter. 81.99% of the shares are held by hedge funds and other institutional investors.

Meanwhile, Zacks Investment Research downgraded Scholar Rock from a “hold” rating to a “sell” rating in a report released Thursday, July 15. One investment analyst rated the stock with a sell rating and five gave the stock a buy rating. Based on data from MarketBeat.com, Scholar Rock currently has an average rating of “Buy” and a consensus target price of $ 61.60.

About Scholar Rock

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative drugs. The company offers a proprietary platform designed to discover and develop monoclonal antibodies with a high degree of specificity to achieve selective modulation of growth factor signaling.

Recommended Story: How To Calculate The Annual Depreciation Rate

This instant news alert was powered by narrative science technology and MarketBeat financial data to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $ 1,000 in Scholar Rock now?

Before you consider Scholar Rock, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks that top analysts quietly whisper to their clients to buy now before the larger market takes hold of… and Scholar Rock was not on the list.

While Scholar Rock currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better bets.

See the 5 actions here